Որոնման արդյունքները - Ouppatham Supasyndh
- Ցուցադրվում են 1 - 8 արդյունքները 8
-
1
-
2
-
3
-
4
-
5
Efficacy and Safety of Sacubitril/Valsartan (LCZ696) Compared With Olmesartan in Elderly Asian Patients (≥65 Years) With Systolic Hypertension Ouppatham Supasyndh, Jianan Wang, Kudsia Hafeez, Ying Zhang, Jack Zhang, Hiromi Rakugi
Հրապարակվել է 2017Artigo -
6
-
7
Effect of Oral Anabolic Steroid on Muscle Strength and Muscle Growth in Hemodialysis Patients Ouppatham Supasyndh, Bancha Satirapoj, Pornanong Aramwit, Duangkamol Viroonudomphol, Amnart Chaiprasert, Vipa Thanachatwej, Supat Vanichakarn, Joel D. Kopple
Հրապարակվել է 2012Artigo -
8
Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension Kazuomi Kario, Ningling Sun, Fu‐Tien Chiang, Ouppatham Supasyndh, Sang Hong Baek, Akiko Inubushi-Molessa, Ying Zhang, Hiromi Gotou, Martin Lefkowitz, Jack Zhang
Հրապարակվել է 2014Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Internal medicine
Medicine
Endocrinology
Gastroenterology
Pathology
Alternative medicine
Cardiology
Dialysis
Hemodialysis
Nephrology
Placebo
Angiotensin II
Biology
Blood pressure
Environmental health
Kidney disease
Population
Surgery
Valsartan
Acute kidney injury
Albuminuria
Ambulatory blood pressure
Anabolism
Biochemistry
Body weight
Cell biology
Dermatology
Diabetes mellitus
Diabetic nephropathy
Diastole